Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Capital Leases (2018)

Historic Capital Leases for Zevra Therapeutics (ZVRA) over the last 3 years, with Q4 2018 value amounting to $396000.0.

  • Zevra Therapeutics' Capital Leases changed N/A to $396000.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $396000.0, marking a year-over-year change of. This contributed to the annual value of $396000.0 for FY2018, which is N/A changed from last year.
  • Latest data reveals that Zevra Therapeutics reported Capital Leases of $396000.0 as of Q4 2018.
  • Zevra Therapeutics' Capital Leases' 5-year high stood at $515000.0 during Q1 2018, with a 5-year trough of $3000.0 in Q3 2015.
  • Over the past 3 years, Zevra Therapeutics' median Capital Leases value was $211000.0 (recorded in 2014), while the average stood at $235750.0.